Drug Report History #128180
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v12-FR | Version v3-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2020-12-04 (Updated) | 2020-11-19 |
| Drug Identification Number | 02242068 | 02242068 |
| Brand name | TRILEPTAL 300 MG | TRILEPTAL 300 MG |
| Common or Proper name | TRILEPTAL FCT 300MG 5 X 10 | TRILEPTAL FCT 300MG 5 X 10 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC | NOVARTIS PHARMACEUTICALS CANADA INC |
| Ingredients | OXCARBAZEPINE | OXCARBAZEPINE |
| Strength(s) | 300MG | 300MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 5 X 10 | 5 X 10 |
| ATC code | N03AF | N03AF |
| ATC description | ANTIEPILEPTICS | ANTIEPILEPTICS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2020-11-06 | 2020-11-06 |
| Actual start date | 2020-11-06 (Updated) | |
| Estimated end date | 2020-11-30 (Updated) | 2020-11-24 |
| Actual end date | 2020-11-30 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Demand increase due to generic backorder. Limited stock available being allocated based on customer profile. | Demand increase due to generic backorder. Limited stock available being allocated based on customer profile. |
| Health Canada comments |